Vol 5, No 1 (2025)

Peer-Reviewed Article

Mapping the Landscape of Infusion Care for People Prescribed IV Medicines in Canada

Quinn Grundy, Dana Hart, Sarah Elkhalifa, Joel Lexchin, Marc-André Gagnon, Navindra Persaud, Mina Tadrous

Published January 30, 2025

PDF HTML

Severity Weighting of Quality-Adjusted Life-Years for Economic Evaluation: What, How, and Where Next?

Shehzad Ali, Alexander Haines, Karen Lee

Published January 20, 2025

PDF HTML

Reimbursement Recommendations

Amivantamab (Rybrevant)

CDA-AMC

Published January 29, 2025

PDF HTML

Erdafitinib (Balversa)

CDA-AMC

Published January 28, 2025

PDF HTML

Ravulizumab (Ultomiris)

CDA-AMC

Published January 10, 2025

PDF HTML

Spesolimab (Spevigo)

CDA-AMC

Published January 7, 2025

PDF HTML

Exagamglogene Autotemcel (Casgevy)

CDA-AMC

Published January 6, 2025

PDF HTML

Exagamglogene autotemcel (Casgevy)

CDA-AMC

Published January 6, 2025

PDF HTML

Ferric Carboxymaltose (Ferinject)

CDA-AMC

Published January 6, 2025

PDF HTML

Health Technology Reviews

Virtual Mental Health Counselling

CDA-AMC

Published January 17, 2025

PDF HTML

Methadone for Surgical Patients

CDA-AMC

Published January 3, 2025

PDF HTML

Reimbursement Reviews

Pembrolizumab (Keytruda)

CDA-AMC

Published January 30, 2025

PDF HTML

Osimertinib (Tagrisso)

CDA-AMC

Published January 27, 2025

PDF HTML

Ivosidenib (Tibsovo)

CDA-AMC

Published January 21, 2025

PDF HTML

Secukinumab (Cosentyx)

CDA-AMC

Published January 17, 2025

PDF HTML

Cabotegravir (Apretude)

CDA-AMC

Published January 16, 2025

PDF HTML

Cariprazine (Vraylar)

CDA-AMC

Published January 16, 2025

PDF HTML

Remdesivir (Veklury)

CDA-AMC

Published January 8, 2025

PDF HTML

Capivasertib (Truqap)

CDA-AMC

Published January 6, 2025

PDF HTML

View All Issues

Table of Contents

Peer-Reviewed Article

Reimbursement Recommendations

Health Technology Reviews

Reimbursement Reviews